Skip Navigation HRSA - U.S Department of Health and Human Services, Health Resources and Service Administration HHS
Home
Questions
Order Publications
 
Grants Find Help Service Delivery Data Health Care Concerns About HRSA
Performance Review
 

Clinical Measures for Health Center Grantee Performance Reviews –
Calendar Year 2006


Performance Measure: #13a   Activity Code(s): H 80  
Percentage of all dental patients with a comprehensive or periodic recall oral exam, for whom the Phase 1 treatment plan is completed within a 12 month period.
 
Definition:
Numerator:

Member of denominator sample who had completed DTaPx4 IPVx3, MMRx1, HepBx3 and Hibx3 (43133).
Denominator: Sample of the sample frame of children aged 2 years. This may be:

The cohort of children who had second birthday during calendar year, with measurement of vaccine status based on shots given prior to 2nd birth date.
or
The cohort of children who are between 19 and 35 months old at time of data extraction.
or
From immunization registry or EHR/EMR, if there is one.
Unit & Text: numerator count/ denominator count x 100 = %
 
National Benchmark:

Healthy People 2010 Objective 14-24: Increase the proportion of young children who receive all vaccines that have been recommended for universal administration for at least 5 years. Increase the proportion of children aged 19 through 35 months who received all recommended vaccines to 80 percent. (Baseline: 73 percent in 1998).

In 2004, HEDIS reported rates of 76.4% for commercial plans and 65.4 for Medicaid plans.

Health Disparities Collaborative, Prevention Pilot, Measure #5a http://healthdisparities.net/hdc/html/collaboratives.topics.prevention.asp

Data Sources
and Data Issues:

From Registry or EHR/EMR if available.

If Chart Audit, then sample from the sample frame of persons meeting denominator criteria.

 
Background/significance of the measure:

Immunizations are one of the safest and most effective ways to help prevent serious infectious diseases and save lives. While immunization coverage among children in the United States is high, it is imperative to maintain high levels of vaccination compliance to prevent resurgences of vaccine-preventable diseases.

Currently, more than 20 percent of 2-year-olds within the United States are still missing one or more
recommended immunizations.

Vaccine-preventable diseases have a costly impact, resulting in doctor's visits, hospitalizations, diability, and premature deaths. Sick children can also cause parents to lose time from work.

A few examples of diseases that have been drastically reduced due to vaccines:
A 1916 polio epidemic in the U.S. killed 6,000 people and paralyzed 27,000 more. In the early 1950’s, there were more than 20,000 cases of polio annually. In 1955 polio vaccination began, virtually eliminating polio in our nation. The success of the polio vaccine campaign in the U.S. and other countries has lead to a word-wide effort to eliminate this dreaded illness.
For more about polio and polio vaccine, see:
http://www.nlm.nih.gov/medlineplus/polioandpostpoliosyndrome.html#overviews

Measles is one of the most easily spread infectious diseases in the world. 90 percent of people not immune to measles will contract the virus if exposed.1 Measles is often thought of as a mild illness, but it can cause sequellae such as sever scarring, encephalitis (brain inflammation) and death. If the measles vaccine was discontinued in the United States, 3-4 million measles cases would occur annually and result in more than 1,800 deaths, 1,000 cases of encephalitis, and 80,000 cases of pneumonia.

Before implementation of the VZV (chicken pox) vaccination program, an annual 4 million cases, 11,000 hospitalizations and 100 deaths were attributable to VZV-preventable diseases. Every dollar spent on varicella vaccine saves 90 cents in direct medical savings and $5.40 in indirect costs.

One third of lifelong hepatitis B virus infections (which can lead to liver failure and death) result from infections in infants and young children. Every dollar spent on hepatitis B vaccine saves 50 cents in direct medical savings and $3.10 in indirect costs.

Infectious diseases remain important causes of preventable illness in the United States despite significant reductions in incidence in the past 100 years. Vaccines are among the safest and most effective preventive measures. This measure indicates health centers level of compliance with current public health and accepted evidence-based medical treatment protocols and prevention standards.

See: http://www.cdc.gov/nip/ACIP/default.htm
Child Schedule: http://www.cdc.gov/nip/recs/child-schedule.htm
http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?doc_id=446

Note that although the measure is still based on the “43133” panel of antigens, the current schedule actually also calls for Varicella (VZ) x 1 and Pneumococcal Conjugate (PCV) x 4 doses; also Hib can be 3 or 4 doses depending on product used. See:
See: http://www.ncqa.org/Docs/SOHCQ_2005.pdf (p. 32 – combination 1 vs. combination 2)
http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?doc_id=447
http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?doc_id=7440

This measure is also in the Health Disparities Collaborative, Prevention Pilot, Measure #5a http://healthdisparities.net/hdc/html/collaboratives.topics.prevention.asp